CORPORATE TAKEOVERNHS Spending on Private Sector is Up – But Patient Outcomes Are Down
In the second part of her investigative series on corporate interests in the NHS, Sian Norris explores how private sector NHS spending has increased – but so have waiting lists, staff vacancies, and patient dissatisfaction
An increase in private interests in the NHS has not necessarily led to improved outcomes for patients, analysis by Byline Times reveals.
In 2019/20, the NHS spent £9.7 billion on services delivered by the private sector – an increase of 14% since 2014/15 and a £0.5 billion increase on the previous year.
The amount spent on private sector healthcare-related providers has steadily grown since 2010. In 2009/10, the “total spend on the independent sector” by NHS commissioners was £4.14 billion. This increased to £8.067 billion in 2014/15, and then £9.007 billion in 2016/17.
During the period of increased private sector provision, austerity policies meant that NHS budgets grew at a slower rate than they had at any time since it was founded. Budgets rose by 1.4% each year on average (adjusting for inflation) between 2009/10 to 2018/19, compared to the 3.7% average rises since the NHS was established.
Demand for health services has also increased during this time, impacting on real-term spending. When health spending figures account for population changes, the average annual growth in per person spending between 1949/50 and 2016/17 was about 3.3%, compared to 0.6% between 2009/10 and 2016/17.
The £9.7 billion spent in 2019/20 excludes spending on services provided by the voluntary and not-for-profit sectors and local authorities, as well as primary care services such as GPs, pharmacists, opticians and dentists. When these additional sectors are included, some have estimated that approximately 25% of NHS spending goes to the private sector.
There are multiple pressures on the NHS, including an ageing population with more complex and long-term health needs and, of course, the Coronavirus pandemic. All of these factors will impact the service’s efficiency. But with private providers heralded as the answer to the NHS’ problems, is the increase in independent sector spending yielding the best possible results?
Down in the Rankings
In 2010, the US think tank, the Commonwealth Fund, found that, in terms of “only minor changes needed”, the UK’s health service was leading the way over other developed nations such as France, the US, Canada and the Netherlands. In 2014 and 2017, the Commonwealth Fund found that the UK had the best health service in the world.
However, in 2021, the UK’s ranking among wealthy countries’ health services fell to fourth place out of 11 for access to care, administrative efficiency and equity; and fifth place for care processes. Worst, the NHS came ninth for healthcare outcomes, which measures how well patients recover after undergoing medical treatment.
The US, which famously has a privatised health system, ranked lowest of all.
The rankings suggest that Britain is moving closer to the US, not only in terms of private provision, but also health outcomes. But how does the UK compare to the rest of Europe?
Data from 2017 found that the UK has 2.7 hospital beds per 1000 population, compared to 8.2 in Germany, and 6.2 and in France. Ireland and Sweden have 2.6 and 2.5 respectively. However, a lower number of beds could be the result of people spending less time in hospital or moving from hospital care to care in the community.
When it comes to staffing levels, there are real areas of concern for the UK. In 2017, the UK had one of the lowest numbers of practising doctors per population and the number of nurses was lower than in France, Germany and the Netherlands. A crisis in staffing has put pressure on GP services in particular: there are now 0.46 fully qualified GPs per 1,000 patients in England.
In terms of funding, 2017 data shows the UK spent the least per capita on healthcare compared to Australia, Canada, Denmark, France, Germany, the Netherlands, Sweden, Switzerland, and the US. In 2018, the UK spent £3,227 per person, rising to £3,278 in 2020.
The UK also had slightly below average life expectancy in comparison to the nine countries analysed, and slightly below average cancer survival rates, including breast, cervical, colon, and rectal cancer.
According to 2019 data, UK women had the lowest life expectancy for women out of eight EU nations: Spain, France, Italy, Sweden, Ireland, Greece and Germany. It ranked six out of eight for men’s life expectancy.
A Mental Health Crisis
One of the areas of care where private sector interests have had the most success is mental health. 44% of spending on child and adolescent mental health is now going to private providers. In Bristol, North Somerset and Gloucestershire, 95% of mental health beds are owned by private companies, two-thirds of which originate in the US.
The Competition and Markets Authority estimated the market for mental health services was worth a total of £15.9 billion in 2015. The private hospital sector had grown by 8% in the previous five years, while NHS capacity had been cut by 23%.
But the mental health service, and young people’s mental health care provision, is in crisis despite increased private sector involvement.
A survey of GPs published in the British Medical Journal found that of 1,000 UK GPs, 99% feared that “young people may come to harm while waiting for specialist mental health treatment from Child and Adolescent Mental Health Services”.
In adult services, the charity Mind found that people struggling with their mental health faced long waits and poor quality care. Only 14% of people the charity surveyed said that they felt they had all the support they needed when in crisis, and less than a third (29%) said that they felt all staff treated them with respect and dignity.
Mind found that 41% of services have staffing levels well below established benchmarks. Waiting times are also an issue: the Royal College of Psychiatrists reported in October 2020 that nearly two-thirds (64%) of people struggling with mental health waited more than four weeks between an initial assessment and a follow-up appointment. One in four (23%) wait more than three months, and 11% wait longer than six months.
Waiting Lists and Satisfaction
It is not only mental health services’ waiting lists that are causing concern.
GP surgeries are an area that has seen increasing private sector involvement – with one US-based private company Centene now running 69 GP practices in London and across England. It joins other private companies with interests in GP surgeries such as SSP Health, Intrahealth and Malling Health.
GPs have always been run independently, but the sector opened up to big corporate interests when the Alternative Provider of Medical Services (APMS) contract was introduced in 2004. This change allowed for the possibility of services being run by private companies rather than GP partnerships.
Survey data based on more than 8,000 GP practices compared the mean satisfaction scores for practices run by APMS contracts with those run by the standard General Medical Services (GMS) contract. Those on APMS contracts performed substantially worse on four out of five key indicators: frequency of consulting a preferred doctor, ability to get a convenient appointment, rating of doctor communication skills, ease of contacting the practice by telephone, and overall experience.
This reflects patient survey data showing that, in 2019, just under 50% of patients said that they “see or speak to their GP always, almost always or a lot of the time” compared to just under 70% in 2012. This could be linked to over-reliance on locum staff in APMS-run GP services.
Elsewhere in the health service, the percentage of people being treated for cancer within 62 days of diagnosis has fallen from just under 88% in 2010 to a low of just under 78% in 2018/19, recovering very slightly in 2019/20.
The number of people receiving treatment in Accident and Emergency within four hours of arrival has also decreased: at around 97% of patients in 2010, compared to around 85% in 2018/19. The number of people receiving elective treatment within 18 weeks has also dropped by 10% between 2012/13 and 2018/19 to 85% of patients.
In this period, spending on private sector provision across health has more than doubled.
While it is true that a variety of complex issues are resulting in pressures on the NHS, and that we cannot know what the picture would look like if different spending decisions had been made over the past decade, Byline Times’ analysis shows a decline in positive health outcomes with an increase in private sector provision.
OUR JOURNALISM RELIES ON YOU
Byline Times is funded by its subscribers. Receive our monthly print edition and help to support fearless, independent journalism.
Thank you for reading this article
New to Byline Times? Find out more about us
SUBSCRIBE TO THE PRINT EDITION
A new type of newspaper – independent, fearless, outside the system. Fund a better media.
Don’t miss a story…
Our leading investigations include Brexit, Empire & the culture war, Russian interference, Coronavirus, cronyism and far right radicalisation. We also introduce new voices of colour in Our Lives Matter.